A Phase I Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Assess the toxicity of hypofractionated radiation therapy as definitive treatment for low and intermediate risk prostate cancer.
With at least one status check visit during the course of treatment.
Michael Zelefsky, MD
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
|Memorial Sloan-Kettering Cancer Center||New York, New York 10021|
|Montefiore Medical Center||Bronx, New York 10467-2490|
|Memorial Sloan-Kettering at Mercy Medical Center||Rockville Centre, New York|
|Memoral Sloan Kettering Cancer Center@Phelps||Sleepy Hollow, New York|